Reckitt Benckiser Group plc (RBGLY) Stock Price & Analysis
Reckitt Benckiser Group plc (RBGLY) is trading at USD 14.88, down 1.20% today, as of October 23, 2026 at 16:11 UTC (US market open; quotes may be delayed), according to Nexqual market data.
RBGLY last closed at USD 15.06; today's session has ranged USD 14.85–15.03 on volume of 8,447 shares. Market capitalization is $47.14B, with a 52-week range of USD 12.02–17.8 (OQX). Source: Nexqual, retrieved October 23, 2026 at 16:38 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RBGLY.md
Key facts (RBGLY)
- Analysts: Buy (mean 2.25 on a 1–5 scale) (4 analysts), mean target USD 16.46 (range 14.58–18.84).
- Total return with dividends: 1Y -1.5% vs S&P 500 +14.6%; 5Y +10.0% vs S&P 500 +77.3%.
Analysts (RBGLY)
Consensus Buy (mean 2.25 on a 1–5 scale), 4 analysts; mean target USD 16.46 (low 14.58, high 18.84).
Total return (dividends reinvested) (RBGLY)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -1.5% | +10.0% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | -1.5% | +1.9% |
| Volatility (annualized) | 24.5% | 24.5% |
| Max drawdown | -30.1% (Feb 2026→Jun 2026) | -36.1% (Jan 2022→Apr 2024) |
RBGLY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $3.39B | — |
| Next quarter (ends Dec 2026) | — | — | — | $3.40B | — |
| Current fiscal year (ends Dec 2026) | $0.67 | $0.67 | -0.3% | $13.07B | 2 |
| Next fiscal year (ends Dec 2027) | $0.71 | $0.71 | -1.0% | $13.46B | 2 |
Key Statistics (as of October 23, 2026 at 16:38 UTC)
| Price | USD 14.88 |
|---|---|
| Change | ▼ 1.20% (down) |
| Previous Close | USD 15.06 |
| Open | USD 15.03 |
| Day Range | USD 14.85 – 15.03 |
| 52-Week Range | USD 12.02 – 17.8 |
| Volume | 8,447 shares |
| Market Cap | $47.14B |
| Exchange | OQX |
Technical Analysis (RBGLY)
Nexqual's technical model rates RBGLY "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of October 23, 2026 at 16:38 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.51 (neutral) |
| vs SMA50 | Above (USD 13.85) |
| MACD | 0.36 (positive) |
Analyst Ratings (RBGLY)
Wall Street analysts rate RBGLY "Buy" based on 4 analysts, with a mean price target of USD 16.46 (range USD 14.58–18.84), per Nexqual as of October 23, 2026 at 16:38 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 16.46 |
| High Target | USD 18.84 |
| Low Target | USD 14.58 |
| Buy / Hold / Sell | 2 / 2 / 0 |
Earnings (RBGLY)
| Revenue Estimate | $3.39B |
|---|
Source: Nexqual, October 23, 2026 at 16:38 UTC.
Financials & Fundamentals (RBGLY)
| Total Revenue | $13.64B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -8.20% |
| Gross Margin | +59.57% |
| Operating Margin | +18.19% |
| Profit Margin | +21.09% |
| ROE | +48.02% |
| Debt / Equity | 1.8 |
| Current Ratio | 0.59 |
| Total Cash | $878.00M |
| Total Debt | $10.25B |
Source: Nexqual, October 23, 2026 at 16:38 UTC.
Financial Health Score (RBGLY)
Nexqual rates Reckitt Benckiser Group plc's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:38 UTC.
| Growth | Mixed — Revenue +0.3% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 60%, operating 18% (last 12 months) |
| Balance Sheet | Critical — GBP 878M cash vs GBP 10.3B debt |
| Cash Flow | Solid — Operating cash flow GBP 2.10B (TTM) |
| Efficiency | Strong — ROE 48%, ROA 7.9% |
Ownership (RBGLY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.15% |
| Shares Outstanding | 3.17B |
| Float | 3.15B |
Source: Nexqual, October 23, 2026 at 16:38 UTC.
Leadership (RBGLY)
Reckitt Benckiser Group plc is led by Kristoffer Loe Licht, CEO & Executive Director, per Nexqual as of October 23, 2026 at 16:38 UTC.
| CEO & Executive Director | Kristoffer Loe Licht |
|---|---|
| CFO & Executive Director | Shannon Sue Eisenhardt |
| Senior Vice President of Investor Relations | Nicholas James Ashworth C.F.A. |
| President North America | Jerome Lemaire |
| President of Nutrition | Susan Sholtis |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EL | Estee Lauder Companies, Inc. (T | USD 108.19 | ▲ 0.44% |
| KVUE | Kenvue Inc. | USD 19.48 | ▼ 2.04% |
| KMB | Kimberly-Clark Corporation | USD 109.62 | ▼ 2.4% |
| CL | Colgate-Palmolive Company | USD 93.86 | ▼ 3.62% |
| CHD | Church & Dwight Company, Inc. | USD 105.49 | ▼ 3.1% |
| UL | Unilever PLC | USD 66.01 | ▼ 1.48% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:38 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt